Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors

BACKGROUND: The use of baseline tumor burden (TB) as a prognostic factor for non‐small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) and associations between TB and other prognostic biomarkers remain unclear. In this study, we investigated the association between...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Thorac Cancer
Prif Awduron: Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya, Shingu, Naoki, Yasuda, Yuko, Eguchi, Yoshitomo, Hisanaga, Jumpei, Nitawaki, Tatsuya, Iio, Miwa, Sekido, Yuko, Nakano, Aiko, Sakagami, Takuro
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons Australia, Ltd 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885438/
https://ncbi.nlm.nih.gov/pubmed/31679185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13214
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg